Human Immunology Biosciences (HI-Bio) is a clinical-stage biotechnology company developing precision therapies for patients with immune-mediated diseases (IMDs). It provides therapy programs from early discovery through clinical development based on disease cellular drivers research. The company works in the fields of human genetics, immunophenotyping, therapeutic engineering, and data science.